» Articles » PMID: 6148575

Hormones As Cancer Growth Factors

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1984 Oct 13
PMID 6148575
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

It is postulated that some hormones may regulate proliferation of cancer cells in the same way as growth factors produced by cellular oncogenes. The gene coding for the hormone's specific receptor would also act as a cellular oncogene. Normal adult breast cells show few if any oestrogen receptors. In the model put forward the oestrogen receptors in breast cancer cells should not be regarded as a marker of differentiation but as a survival advantage for the tumour when oestrogens are present. Prolactin and somatomedin may also behave as growth factors. In relation to the antitumour effects of hormone antagonists such as tamoxifen, it is postulated that cancer cells are immortalised and prevented from full differentiation by the presence of growth factors and their receptors. If receptor genes are re-expressed through the process of neoplastic transformation, their presence in cancers from unresponsive normal tissues should be regarded as a common event.

Citing Articles

Differential action of glycoprotein hormones: significance in cancer progression.

Govindaraj V, Arya S, Rao A Horm Cancer. 2013; 5(1):1-10.

PMID: 24129797 PMC: 10358072. DOI: 10.1007/s12672-013-0164-8.


Oestrogen and progesterone receptor distribution in the cancerous breast.

Panahy C, Puddefoot J, Anderson E, Vinson G, Berry C, Turner M Br J Cancer. 1987; 55(4):459-62.

PMID: 3580270 PMC: 2001706. DOI: 10.1038/bjc.1987.90.


Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states.

Rutteman G, Misdorp W, Blankenstein M, van den Brom W Br J Cancer. 1988; 58(5):594-9.

PMID: 3219269 PMC: 2246835. DOI: 10.1038/bjc.1988.266.


Oestrogen receptor activity in intraduct and invasive breast carcinomas.

Hawkins R, Tesdale A, FERGUSON W, Going J Breast Cancer Res Treat. 1987; 9(2):129-33.

PMID: 3040158 DOI: 10.1007/BF01807365.


Accelerated genetic destabilization and dormancy: two distinct causes of resistance in metastatic cells; clinical magnitude, therapeutic approaches.

Israel L Clin Exp Metastasis. 1990; 8(1):1-11.

PMID: 2403488 DOI: 10.1007/BF00155588.